Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

Annual Meeting 2016

Annual Meeting Materials

The Annual Meeting of Shareholders will be held:

Wednesday, May 11, 2016, 8:30 a.m. ET
Goodwin Procter LLP
Exchange Place
53 State Street
Boston, Massachusetts 02109

Before you vote, you should carefully review our 2016 Proxy Statement, Form 10-K for fiscal year 2015, 2015 Annual Report, and related materials that were mailed on or around March 31, 2016, to shareholders of record as of March 15, 2016. For your convenience, these materials may be viewed by selecting the links below:

To view the PDF version of these documents, you will need Adobe Acrobat; click here for detailed download instructions.

Related Links

Corporate Governance  | SEC Filings  | Contact Information

Stock Quote

CRL (common)
Price
$109.34
Change (%)
+ 3.71 (3.51%)
Volume
390,653
Exchange
NYSE
Data as of 02/23/18 4:02 p.m. ET
Data provided by Nasdaq.
Minimum 15 minutes delayed.

Refresh Quote

Investor Hotline

877-567-6CRL (6275)